NSE filing, NSE: MRF. Summary written from the filing by ALFA Finder's alert engine.
MRF Ltd: key numbers
- Share price
- ₹1,18,020.00
- Market cap
- ₹50,053 Cr
- Revenue (annual)
- ₹31,149 Cr
- Net profit (annual)
- ₹2,426 Cr
- P/E (TTM)
- 20.7×Sector 30.9×
- Promoter holding
- 27.61%-0.16% QoQ
- FII holding
- 17.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from MRF Ltd
All →MRF Promoter Selling (Off-Market)
Promoter group member Ms. Beebi Mammen gifted her entire stake in MRF Ltd to her children. The transfer has been completed and reflected in shareholding.
MRF Legal & Regulatory
MRF announced that the tax demand for the FY 2014-15 CST assessment was reduced by authorities from Rs. 91.53 crore to Rs. 36.19 crore.
- Value
- ₹36.19 Cr
MRF Management Change
MRF Limited has appointed Mr. Prasanth Puliakottu and Mr. Santhosh Mathew as Senior General Managers. These appointments strengthen the company's senior management team.
MRF Results Update
MRF Limited reported a consolidated total income of Rs 8610.56 Crore for Q1 FY27. Net profit for the period stood at Rs 495.35 Crore.
- Value
- ₹8,611 Cr
MRF Q1 FY27 Results: Net Profit ₹495.4 Cr, Down 1.3% YoY
MRF Ltd reported revenue from operations of ₹8,416 Cr (+9.6% YoY) and net profit of ₹495.4 Cr (-1.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹495.4 Cr · -1.3% YoY
MRF Annual General Meeting
MRF Limited held its 65th AGM on August 6, 2026. Shareholders approved financial statements, director re-appointments, and a final dividend of Rs. 229 per share.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.